Tag Archive | "insight"

Dermatology partnering – recent deals analysis 2009-2014

Tags: , ,

Partnering in the last decade has seen an increase in dermatology with an rise specifically in modern diagnostic technologies. Read the full story

Biopharmaceuticals: The 2011 Health Care Value Creators Report

Tags: , ,

Written by Michael Ringel, Colm Foley and Olivier Wierzba for Boston Consulting Group (BCG).
The five-year period covered in this report was a stormy time for the bio-pharma sector. While sales growth remained strong, expectations for future growth declined significantly. P/E ratios for large-cap biopharma, a formidable 35x in 2000, plunged to 11x by 2010.
The challenges underlying this decline are well known and include pricing and access pressures, higher scientific hurdles, more-stringent regulatory thresholds, and intensifying competition. The average return on investment (ROI) in R&D for new products—the lifeblood of the sector—is now below the cost of capital, making average R&D value destroying. However, performance on this measure varied widely during our study period, and some companies consistently found ways tobeat the average.

Read the full story

The 2011 Health Care Value Creators: How can healthcare companies create more value?

Tags: , ,

The 2011 Healthcare Value Creators Report. Written by Michael Ringel, Colm Foley and Olivier Wierzba for Boston Consulting Group (BCG).

Strength in the Storm: How Biopharmaceutical and Medical Technology Companies Can Create Value in a Challenging Business Environment builds on the thirteenth annual report in the Value Creators series published by The Boston Consulting Group (BCG).   Read the full story